```html

Keratouveitis: A Comprehensive Medical Guide

Overview

Keratouveitis (also called keratouveal inflammation) is a combined inflammation of the cornea (keratitis) and the uveal tract (uveitis). Because both structures share a common blood‑ocular barrier, an insult that triggers inflammation in one often spreads to the other. The condition can be acute or chronic and may arise from infectious agents, autoimmune disease, trauma, or post‑surgical complications.

• Who it affects: Adults aged 20‑60 are most commonly diagnosed, but children and the elderly can be affected, especially after ocular injury or surgery.
• Prevalence: Precise worldwide figures are limited, but uveitis accounts for ~10‑15 % of legal blindness in the United States, and keratitis contributes to ~2 % of all ophthalmic emergencies. Approximately 1‑3 % of uveitis cases involve concurrent corneal involvement, translating to an estimated 30 000–50 000 new cases annually in the U.S. alone <sup>[1][2]</sup>.
• Impact: If untreated, keratouveitis can lead to permanent corneal scarring, cataract, glaucoma, or vision loss.

Symptoms

Symptoms may develop rapidly (hours) or insidiously over days. Because inflammation involves two ocular structures, patients often experience a mix of corneal and uveal signs.

Ocular pain and discomfort

• Burning, gritty sensation (“like sand in the eye”)
• Deep, aching pain that may radiate to the forehead or jaw

Redness

• Diffuse conjunctival hyperemia (pink eye)
• Deep “ciliary injection” around the limbus indicating uveal inflammation

Visual changes

• Blurred or decreased vision, often worse in low light
• Photophobia (light sensitivity) due to corneal epithelial disruption

Corneal findings

• White or infiltrative lesions on the cornea (ulcers, stromal haze)
• Edema causing a hazy cornea
• Decreased corneal transparency, sometimes with a “spoke‑wheel” pattern

Uveal findings

• Cellular or fibrinous reaction in the anterior chamber (detectable with a slit‑lamp)
• Pupil irregularities (posterior synechiae – adhesions of the iris to the lens)
• Secondary glaucoma from trabecular meshwork blockage

Other possible symptoms

• Tearing (excessive lacrimation)
• Foreign‑body sensation
• Floaters or flashes if posterior segment involvement occurs (rare)

Causes and Risk Factors

Keratouveitis is a syndrome rather than a single disease; the underlying cause dictates management.

Infectious agents

• Bacterial: Staphylococcus aureus, Pseudomonas aeruginosa (often after contact‑lens wear), Haemophilus influenzae
• Viral: Herpes simplex virus (HSV), Varicella‑zoster virus (VZV), Adenovirus (epidemic keratoconjunctivitis)
• Fungal: Fusarium, Aspergillus (more common in tropical climates or after trauma with vegetative matter)
• Parasitic: Acanthamoeba (often linked to poor contact‑lens hygiene)

Non‑infectious (immune‑mediated) causes

• Systemic autoimmune diseases – Behçet’s disease, ankylosing spondylitis, sarcoidosis, inflammatory bowel disease
• HLA‑B27 associated uveitis (often in young males)
• Granulomatosis with polyangiitis (Wegener’s)
• Idiopathic – no identifiable systemic disease (≈30 % of cases) <sup>[3]</sup>

Trauma and surgery

• Penetrating or blunt eye injury
• Post‑operative inflammation after cataract extraction, corneal transplant, or refractive surgery

Risk factors

• Contact‑lens wear, especially extended‑wear or poor hygiene
• History of recurrent herpes eye disease
• Systemic autoimmune disease
• Immunosuppression (HIV, chemotherapy, organ transplantation)
• Occupational exposure to dust, plant material, or chemicals

Diagnosis

Accurate diagnosis requires a meticulous eye exam and targeted investigations to identify the underlying cause.

Clinical examination

• Visual acuity testing – baseline for monitoring response to therapy.
• Slit‑lamp biomicroscopy – gold standard to visualize corneal infiltrates, epithelial defects, anterior chamber cells/flare, and synechiae.
• Fluorescein staining – highlights epithelial breakdown and ulcer margins.
• Intra‑ocular pressure (IOP) measurement – important because uveitic inflammation can raise pressure.

Ancillary tests

• Corneal scraping & culture – Gram stain, bacterial/fungal cultures, and PCR for viral DNA when infection is suspected.
• Anterior chamber paracentesis – used for PCR or cytology if diagnosis remains unclear.
• Serologic work‑up – HLA‑B27, ANA, RF, ACE, QuantiFERON‑TB, syphilis serology, and others based on systemic suspicion.
• Imaging – Optical coherence tomography (OCT) of the anterior segment can quantify edema; B‑scan ultrasonography if posterior segment involvement is suspected.

Diagnostic criteria

Diagnosis is confirmed when both corneal inflammation (keratitis) and intra‑ocular inflammation (uveitis) are present, and a specific etiology is identified (or labeled “idiopathic” after appropriate work‑up).

Treatment Options

Treatment revolves around (1) combating the underlying cause, (2) suppressing inflammation, and (3) preserving visual function.

1. Antimicrobial therapy (for infectious keratouveitis)

• Bacterial: Topical fortified antibiotics (e.g., 5 % natamycin for fungi, 0.5 % moxifloxacin or fortified cefazolin + amikacin for bacteria). Severe cases may need systemic antibiotics.
• Viral (HSV, VZV): Oral acyclovir 400 mg five times daily (or valacyclovir 1 g TID) plus topical antiviral ointment.
• Acanthamoeba: Polyhexamethylene biguanide (PHMB) 0.02 % drops hourly, sometimes combined with chlorhexidine.
• Fungal: Natamycin 5 % eye drops hourly; systemic voriconazole if deep stromal involvement.

2. Anti‑inflammatory therapy (non‑infectious or after antimicrobial control)

• Topical corticosteroids: Prednisolone acetate 1 % drops every 1–2 hours, tapered over weeks based on response.
• Cycloplegics: Homatropine 2–5 % or cyclopentolate 1 % BID to relieve ciliary spasm, prevent synechiae, and improve comfort.
• Systemic steroids: Oral prednisone 0.5–1 mg/kg/day for severe or posterior involvement; taper slowly.
• Immunomodulatory agents: For chronic autoimmune keratouveitis, steroid‑sparing drugs such as methotrexate, mycophenolate mofetil, or biologics (adalimumab) are used per rheumatology guidance.

3. Surgical interventions (when medical therapy fails)

• Therapeutic keratoplasty: Penetrating or lamellar corneal graft to remove infected tissue or scarred cornea.
• Anterior chamber washout: To remove infectious debris or inflammatory exudate.
• Glaucoma surgery: Trabeculectomy or tube shunt if IOP remains uncontrolled despite medication.

4. Lifestyle and supportive measures

• Strict hand‑washing and lens hygiene (daily rub‑and‑rinse, replace lenses/solution as recommended).
• Protective eyewear during sports or hazardous work.
• Artificial tears ( preservative‑free) to relieve surface irritation.
• Avoidance of smoke, dust, and allergens that can exacerbate inflammation.

Living with Keratouveitis

Chronic or recurrent disease requires ongoing self‑care and regular follow‑up.

Daily management tips

• Keep a medication diary – note doses, timing, and any side effects.
• Use prescribed eye drops exactly as directed; never skip a dose.
• Store drops in a cool, dry place; discard after the “use‑by” date to avoid contamination.
• Wear sunglasses that block UV light; bright light aggravates photophobia.
• Stay hydrated and maintain a balanced diet rich in omega‑3 fatty acids, which may support ocular surface health.
• Schedule regular ophthalmology visits (often every 1‑3 months during active disease) to monitor corneal clarity and IOP.

Psychosocial considerations

Vision changes can cause anxiety or depression. Encourage patients to:

• Join support groups (e.g., American Uveitis Society forums).
• Seek counseling if mood disturbances arise.
• Use low‑vision aids (magnifiers, high‑contrast reading materials) during periods of reduced vision.

Prevention

While not all cases are preventable, many risk factors are modifiable.

• Contact‑lens hygiene: Replace lenses and cases as recommended; use preservative‑free disinfecting solutions; avoid sleeping in lenses unless approved.
• Eye protection: Safety goggles when handling chemicals, woodworking, or gardening.
• Prompt treatment of minor ocular injuries: Clean tears promptly, seek care for foreign bodies.
• Vaccination: Varicella and shingles vaccines reduce VZV‑related keratouveitis risk.
• Systemic disease control: Maintain tight control of autoimmune conditions with rheumatology follow‑up.
• Regular eye exams: Annual dilated exams help detect early uveitis or corneal changes before they become symptomatic.

Complications

If inflammation persists or treatment is delayed, several sight‑threatening complications may develop.

• Corneal scarring (nebulae or maculae): Permanent opacities that reduce visual acuity.
• Secondary cataract: Posterior subcapsular cataract occurs in up to 30 % of chronic uveitis patients.
• Glaucoma: Elevated IOP from trabecular meshwork obstruction; up to 20 % of uveitis cases develop glaucoma.
• Band‑keratopathy: Calcium deposition in the corneal stroma.
• Permanent vision loss: Rare but possible if retinal or optic nerve involvement occurs.
• Endophthalmitis: Infections extending into the posterior segment, especially after surgery.

When to Seek Emergency Care

---

References:
[1] American Academy of Ophthalmology. “Uveitis Overview.” AAO.org, 2023.
[2] National Eye Institute. “Corneal Disease Statistics.” NIH, 2022.
[3] Jabs DA, et al. “Standardization of Uveitis Nomenclature (SUN) Working Group.” *Ophthalmology*, 2021.

```